Market closed·Syncing…
Market closed · Close · 19 Nov

Health X Platform Limited HEALTHXshare price and chart

Health X Platform closed at ₹272.50 on 19 November 2026, down 0.86% on the day. The 52-week range is ₹252.50 to ₹363.00.

₹272.50The price one share last traded at, in rupees.▼ 0.86% · ₹2.36
52-wk low ₹25318% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹363

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on HEALTHX

Real prices, every charge counted. Pick one or write your own.
What Health X Platform Limited does
A short, human-reviewed summary of the business, written from public sources. Background, not analysis, and not updated intraday.
business summary

Health X Platform, formerly Sastasundar Ventures, is a core investment company with 90% of its funds invested in subsidiaries including Sastasundar Healthbuddy. Wholesale trading of medicines and OTC products is 98.8% of its turnover, across 28 states.

1
1Sector

Healthcare Services

2
2What it sells

Wholesale medicines and OTC products

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
43.7Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
91.4%Near average
today 91.4%20d avg 72.9%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.▼ 4.0%vs 200 DMAHow far today's close is above or below the average closing price of the last 200 trading days, about ten months. It is the most watched line for the long-term trend.▼ 6.7%1 monthHow much the share price has changed over the period.+0.5%3 monthsHow much the share price has changed over the period.▼ 13.1%1 yearHow much the share price has changed over the period.▼ 9.1%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.26.6%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Books to 30 Sept 2026
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹867 Cr19 NovReturn on equityHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.-0.2%full year FY26Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.1.37xbooks of Sept 2026EV / EBITDAWhat it would cost to buy the whole company, against the cash profit its business makes in a year. It is a P/E that ignores how the company is financed.175.4xDividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.04xbooks of Sept 2026FCF marginOf every ₹100 of sales, how much cash was left after running the business and paying for new assets.-6.7%year to Mar 2026

Against its sectorWhere this company ranks among similar companies on each measure.

Healthcare Service Provider · 15 peers · medians
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.-1.41%vs 14.05% median
Lowest: HEALTHX -1.41%Highest: 3BBLACKBIO 35.36%
Revenue growthHow much sales grew in the latest quarter against the same quarter a year earlier.60.66%vs 25.07% median
Lowest: ONEGLOBAL -50.77%Highest: HEALTHX 60.66%

What the numbers sayShort plain statements about this company's latest figures.

Written by fixed rules

Latest quarterIn the quarter to September 2026 (results filed 14 Nov 2026), sales rose 60.7% from a year earlier to ₹484 cr and the loss was ₹12.7 cr against ₹15.4 cr a year earlier.

Going well
  • No promoter shares were pledged at the end of September 2026.
Worth watching
  • Reported a loss in FY25 and FY26.
  • Profit before interest covered interest -2.0 times in FY26 (₹1 cr of interest).
  • Return on equity stayed under 10% from FY24 to FY26 (highest 0.6%).

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

Share price reaction to resultsWhat the share price did around each recent quarterly result.

Over the last 20 results, the share rose on 7 and fell on 13, and moved by 3% or more on 8.

+8%
-8%
Q2 FY23Q2 FY24Q2 FY25Q2 FY26Q2 FY27

Q2 FY27: results filed 14 Nov 2026. The share went from its close on 13 Nov 2026 to its close on 16 Nov 2026 +0.20%.

What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.

Price only, before dividends
+19.6%a year, over 10 years
1 yr
-14.6%
3 yr
-11.9%
5 yr
-10.9%
10 yr
+19.6%

Held for 10 years this compounded at +19.6% a year. The last twelve months were down -14.6%. Price only, before dividends.

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
74.07%promoter holding, as of 2026-09-30-0.4 pts since 2021
Promoter share since listing
2021-0974.07% now, drawn to its own range2026-09
Who owns it todayas of Sep 26
74.1%
21.0%
Promoter74.1%Foreign (FII)2.3%Domestic (DII)2.6%Public & others21.0%
Who is buying, who is leavingJun 25 to Sep 26
Promoter74.1%-0.2 pts
Foreign (FII)2.3%+0.4 pts
Domestic (DII)2.6%+0.5 pts

Each line is that holder's share of all shares over the last 6 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Promoter pledgeThe share of promoters' holdings given to lenders as security for a loan.0.00%of promoter shares, as at 2026-09-30

Insider tradesPurchases and sales of the company's own shares by promoters, directors and senior staff.

Last 18 months
Buy
BANWARI LAL MITTAL
Promoters · 01-Apr-2026 12:51
5,000 sh
₹13.8 L
Buy
BANWARI LAL MITTAL
Promoters · 27-Mar-2026 16:14
5,000 sh
₹14.0 L
Buy
BANWARI LAL MITTAL
Promoters · 23-Mar-2026 12:54
5,132 sh
₹14.4 L
Buy
BANWARI LAL MITTAL
Promoters · 19-Mar-2026 11:18
7,663 sh
₹21.3 L
Buy
BANWARI LAL MITTAL
Promoters · 16-Mar-2026 14:07
11,671 sh
₹32.8 L
Buy
BANWARI LAL MITTAL
Promoters · 13-Mar-2026 12:39
5,286 sh
₹14.7 L
Buy
BANWARI LAL MITTAL
Promoters · 20-Feb-2026 13:41
5,000 sh
₹14.6 L
Buy
BANWARI LAL MITTAL
Promoters · 16-Feb-2026 14:30
8,000 sh
₹24.1 L
Buy
BANWARI LAL MITTAL
Promoters · 31-Dec-2025 18:18
6,835 sh
₹20.6 L
Buy
BANWARI LAL MITTAL
Promoters · 17-Dec-2025 19:48
3,406 sh
₹10.3 L
Buy
BANWARI LAL MITTAL
Promoters · 11-Dec-2025 15:28
10,000 sh
₹30.6 L
Buy
BANWARI LAL MITTAL
Promoters · 08-Dec-2025 16:58
10,280 sh
₹31.9 L
Buy
BANWARI LAL MITTAL
Promoters · 02-Dec-2025 17:34
11,500 sh
₹37.7 L
Buy
BANWARI LAL MITTAL
Promoters · 29-Nov-2025 10:20
10,582 sh
₹34.3 L
Buy
BANWARI LAL MITTAL
Promoters · 22-Nov-2025 18:11
10,000 sh
₹32.2 L

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Analysts/Institutional Investor Meet/Con. Call Updates16-Nov-2026

Health X Platform Limited has informed the Exchange about Link of Recording

Copy of Newspaper Publication16-Nov-2026

Health X Platform Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2026

Investor Presentation14-Nov-2026

Health X Platform Limited has informed the Exchange about Investor Presentation

Outcome of Board Meeting14-Nov-2026

Health X Platform Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Analysts/Institutional Investor Meet/Con. Call Updates07-Nov-2026

Health X Platform Limited has informed the Exchange about Intimation of Schedule of the Earnings Conference Call for Q2 of FY2026-27 and registration Link thereof

Certificate under SEBI (Depositories and Participants) Regulations, 201809-Oct-2026

Health X Platform Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026

Shareholders meeting29-Sep-2026

Health X Platform Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 28, 2026. Further, the company has informed the Exchange regarding voting results.

Shareholders meeting28-Sep-2026

Health X Platform Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2026

Trading Window25-Sep-2026

Health X Platform Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Copy of Newspaper Publication05-Sep-2026

Health X Platform Limited has informed the Exchange about Copy of Newspaper Publication regarding Notice of the 37th Annual General Meeting and e-voting information

Updates04-Sep-2026

Health X Platform Limited has informed the Exchange regarding 'Dispatch of letter to shareholders whose e-mail addresses are not registered with the Company or RTA or Depository Participants' - under Reg 30 and Reg 36(1)(b) of SEBI LODR Reg..

Updates04-Sep-2026

Health X Platform Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report of the Company for the FY 2025-26 '.

Shareholders meeting04-Sep-2026

Health X Platform Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026 at 3.00 PM (IST)

Copy of Newspaper Publication01-Sep-2026

Health X Platform Limited has informed the Exchange about Copy of Newspaper Publication for Information to the shareholders regarding the 37th AGM of the Company to be held on Monday, September 28, 2026

Updates31-Aug-2026

Health X Platform Limited has informed the Exchange regarding 'Intimation regarding the 37th Annual General Meeting of the Company '.

Backtest idea · HEALTHXMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on HEALTHX
Backtest idea · HEALTHXLower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on HEALTHX
Backtest idea · HEALTHXSupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on HEALTHX
Your own ideaWrite a rule for HEALTHX in plain English“Buy HEALTHX when …”
Start writing
Buy the dip on HEALTHXBuy when RSI(14) drops below 30
52-week high breakout on HEALTHXBuy when closes at a 52-week high
Golden cross on HEALTHXBuy when 50-day EMA crosses above 200-day
Stochastic oversold on HEALTHXBuy when stochastic %K drops below 20
Pullback in an uptrend on HEALTHXBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹867 cr
Larger than 47% of 15 peers
sector middle ₹1,130 cr
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
1.4x
Lower than 92% of 13 peers
sector middle 5.4x
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.
-0.2%
Lowest of 8 peers
sector middle 14.9%
FY23 -11.4%FY26 -0.2%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.04
Around the middle of 13 peers
sector middle 0.03
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 53% of 15 peers
sector middle 0.1%
Sales growthHow much sales grew in the latest quarter against the same quarter a year earlier.
+60.7%
Highest of 9 peers
sector middle +25.1%
FY23 119.1%FY26 18.7%

Peers are the listed companies in the exchange's own industry group: Healthcare Service Provider. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Revenue and profit, year by yearSales and net profit by financial year or by quarter.

Sales and net profit
FY22FY23FY24FY25FY26
SalesNet profitfell vs last yearEach on its own scale · hover a bar for its figures
Op. marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax.-3.9%FY26SalesMoney earned from selling the company's goods and services, before any costs. Also called revenue.₹1,319 CrFY26Net profitWhat is left for shareholders after all costs, interest and tax.₹-1 CrFY26

Where every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.

FY26

In FY26, of every ₹100 of sales it kept ₹0.0 as profit. Other income added ₹4.4.

Where it wentPer ₹100 of sales
Running costs₹103.9Depreciation₹0.5Interest₹0.1
Profit per ₹100, year by year
FY22FY26

How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.

Compounded a year
3 years5 yearsLatest qtr
Sales+8.2%-+60.7%
Profit---
3 and 5 years are compounded a year across full financial years. The latest quarter is against the same quarter a year earlier.

Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.

Where the cash went

In FY26 cash rose by ₹18 Cr, after ₹15 Cr spent on plant and equipment.

FY26Cash in or out
Running the business-₹74 Cr
Investing+₹171 Cr
Lenders and shareholders-₹80 Cr
Net change in cash+₹18 Cr

Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.

MeasureFY23FY24FY25FY26
Sales growthSales in this financial year against the previous one.119%-0.0%6.9%18.7%
Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax.-4.2%-0.4%-5.0%-3.9%
Net marginOf every ₹100 of sales in the year, how much was left as profit after everything.-10.9%0.6%-12.1%-0.1%
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.-11.4%0.6%-14.4%-0.2%
Interest coverHow many times the company's profit before interest could pay its interest bill.-40.6x46.4x-963.5x-2.0x

Each row against this company's own usual level: green better, red worse, grey close to it.

Backtest idea · HEALTHXStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on HEALTHX
Backtest idea · HEALTHXPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on HEALTHX
Backtest idea · HEALTHXBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on HEALTHX
Backtest idea · HEALTHX52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on HEALTHX
Backtest idea · HEALTHXGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on HEALTHX
MACD momentum on HEALTHXBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on HEALTHXBuy when closes below the lower Bollinger band
Supertrend rider on HEALTHXBuy when supertrend turns up
Buy the dip on HEALTHXBuy when RSI(14) drops below 30
52-week high breakout on HEALTHXBuy when closes at a 52-week high

Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.

Healthcare Service Provider
CompanyWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.How much operating profit the company made on all the money in the business, whether it came from owners or lenders.Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.Of every ₹100 of sales, how much is left as profit after all costs, interest and tax.How much sales grew in the latest quarter against the same quarter a year earlier.The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
LALPATHLAB
Dr. Lal Path Labs Ltd.
32,952 cr56.2x12.0x21.5%29.1%0.0019.4%+19.6%0.89%
VIJAYA
Vijaya Diagnostic Centre Limited
15,559 cr76.3x14.7x19.7%30.3%0.0022.4%+26.7%0.13%
METROPOLIS
Metropolis Healthcare Limited
11,587 cr51.6x7.1x13.4%19.6%0.0112.7%+15.8%0.36%
THYROCARE
Thyrocare Technologies Limited
8,035 cr56.1x14.5x28.7%37.8%0.0015.4%+25.1%1.39%
NEPHROPLUS
Nephrocare Health Services Limited
6,455 cr49.4x5.4x6.9%13.4%0.0711.5%-0.00%
SURAKSHA
Suraksha Diagnostic Limited
1,718 cr41.1x6.2x13.8%24.8%0.0211.9%+25.8%0.15%
KRSNAA
Krsnaa Diagnostics Limited
1,673 cr17.0x1.6x10.9%12.7%0.5711.1%+31.5%0.39%
3BBLACKBIO
3B Blackbio Dx Limited
1,130 cr19.1x----35.4%+42.4%0.38%
HEALTHX
Health X Platform Limited
867 cr-1.4x-0.2%-0.04-1.4%+60.7%0.00%
CREDENT
Credent Connect N Care Limited
860 cr-6.1x--0.15--0.00%
ONEGLOBAL
One Global Service Provider Limited
749 cr12.0x----14.1%-50.8%0.26%
GAUDIUMIVF
Gaudium IVF and Women Health Limited
724 cr28.7x4.4x16.1%20.4%0.0320.8%-0.00%
CHANDAN
Chandan Healthcare Limited
599 cr-3.5x-22.4%0.32--0.00%
PRAMODINI
Pramodini Medicare Limited
230 cr-2.0x--0.26--0.00%
INVICTA
Invicta Diagnostic Limited
97 cr-1.7x--0.02--0.00%
NIDAN
Nidan Laboratories and Healthcare Limited
18 cr14.8x0.3x-5.5%0.174.8%-8.4%0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
+0.6
-4.6
-9.3
+9.7
+9.1
+0.1
+0.2
-2.1
-5.4
+1.6
-5.9
·
-7.7%
11m
2025
-11.5
-22.2
+11.1
+4.3
+5.7
+11.1
-3.9
-4.4
+11.9
-3.1
+11.1
-10.1
-6.9%
2024
-0.7
-15.1
-12.2
+1.6
-1.4
+11.4
-5.1
-2.6
-4.7
+6.7
-3.7
+3.2
-22.8%
2023
-1.8
-18.2
-2.4
+8.7
+15.6
+3.0
-7.5
+9.0
-5.6
+13.7
+48.8
-10.9
+45.9%
2022
-6.2
-14.5
-8.1
+9.6
-23.2
+0.3
-0.6
+16.7
-10.4
-4.4
+0.7
-7.1
-42.1%
2021
-7.4
+5.9
-7.7
+40.3
+21.2
+53.6
+4.1
-5.1
-5.2
+32.8
+25.1
+2.4
+276.8%
2020
-3.3
-1.4
-15.4
+9.4
-0.7
+33.0
-3.3
+26.1
-17.5
+13.2
+40.3
-3.7
+79.2%
2019
-0.5
+11.1
+14.2
-2.4
-8.5
+2.1
-7.6
+0.4
-5.7
-5.0
-18.6
-2.9
-24.3%
2018
-13.9
-2.2
+0.7
+5.9
-14.9
-16.7
+8.2
+13.2
+0.8
-2.5
-1.6
-1.6
-25.8%
2017
+5.3
+1.9
+25.2
+19.9
+12.9
-15.5
-26.1
-0.8
-3.0
+40.3
+21.2
-7.0
+72.8%
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

No bulk or block deals on record for HEALTHX in the window we hold.

The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.

Read enough? Test HEALTHX. “Buy HEALTHX when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free